Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
Clinical trial NCT04712539 · RECRUITING
Trial details
- NCT number
- NCT04712539
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-11
- Primary completion
- 2028-02-28
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.